Diabetes and acute bacterial skin and skin structure infections. [PDF]
Acute bacterial skin and skin structures infections (ABSSSIs) are associated with high morbidity, costs and mortality in patients with diabetes mellitus. Their appropriate management should include several figures and a well-organized approach.
Aguado JM +6 more
core +6 more sources
Necessity of vancomycin trough concentrations to manage uncomplicated acute bacterial skin and skin structure infections: a laboratory stewardship analysis [PDF]
Background: Recent recommendations by the American Society of Health System Pharmacists and Infectious Disease Society of America have provided guidance regarding vancomycin dosing and monitoring in serious infections (including methicillin-resistant ...
Andrew Merker +3 more
doaj +2 more sources
Acute bacterial skin and skin structure infections: current perspective
A skin and skin structure infection is a bacterial infection of skin and associated tissues. It may be complicated skin and skin structure infection or uncomplicated skin and skin structure infection. Recently, the Food and Drug Administration has called
Megha Shah, Hetal D Shah
doaj +3 more sources
Omadacycline for Acute Bacterial Skin and Skin Structure Infections. [PDF]
Acute bacterial skin and skin-structure infections are associated with substantial morbidity and health care costs. Omadacycline, an aminomethylcycline antibiotic that can be administered once daily either orally or intravenously, is active against pathogens that commonly cause such infections, including antibiotic-resistant strains.In this double ...
Abrahamian FM +7 more
europepmc +7 more sources
Long-Acting Antibiotics: New Opportunities Beyond Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)! [PDF]
Currently, two long-acting antibiotics are available: oritavancin (ORI) and dalbavancin (DBV) [...]
Emanuele Pontali +3 more
doaj +2 more sources
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections. [PDF]
The global spread of antibacterial-resistant strains, especially methicillin-resistant Staphylococcus aureus (MRSA) for acute bacterial skin and skin structure infections (ABSSSIs), has driven the need for novel antibacterials. Delafloxacin [Quofenix™ (EU); Baxdela® (USA)], a new fluoroquinolone (FQ), has a unique chemical structure that enhances its ...
Scott LJ.
europepmc +4 more sources
Financial Analysis of Dalbavancin for Acute Bacterial Skin and Skin Structure Infections for Self-Pay Patients [PDF]
Introduction Acute bacterial skin and skin structure infections (ABSSSI) are an increasing cause of admission in the self-pay population. We previously reported that patients with ABSSSI discharged to receive dalbavancin showed a decreased length of stay
Adam G. Pizzuti +5 more
doaj +2 more sources
Omadacycline for the treatment of acute bacterial skin and skin structure infections: a systematic review and network meta-analysis [PDF]
Background Few studies have compared the efficacy and safety of omadacycline with other treatments for acute bacterial skin and skin structure infections (ABSSSI). Therefore, updated meta-analyses on this topic is necessary.
Wen-qiang Kong +5 more
doaj +2 more sources
Review of oritavancin for the treatment of acute bacterial skin and skin structure infections [PDF]
Objective: To assess critically oritavancin, a second-generation lipoglycopeptide, for the treatment of Acute Bacterial Skin and Skin Structure Infections caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus ...
Ana Alejandra García Robles +4 more
doaj +6 more sources
Cost-analysis from real-world REDS study on dalbavancin in inpatient treatment of acute bacterial skin and skin structure infections [PDF]
Introduction: Inpatient treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) involves a significant economic burden on the healthcare system.
Matteo Scortichini +4 more
doaj +2 more sources

